
浏览全部资源
扫码关注微信
纸质出版日期:2011
移动端阅览
杨薇, 刘芬娣. 自拟利咽方防治放射性食道炎[J]. 中国实验方剂学杂志, 2011,17(17):238-240.
YANG Wei, LIU Fen-di. Clinical Research in Treatment of Radiation Esophagitis with Self-control Liyan Agents[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(17): 238-240.
目的: 观察自拟利咽方防治放射性食道炎的临床疗效。 方法: 60例肺癌放疗患者随机分为2组
治疗组30例自放疗开始至结束予自拟利咽方(100 mL/袋
3次/d)治疗;对照组30例自放疗开始至结束予口服常用西药(20 mL/次
4次/d)治疗。观察治疗前后两组患者放射性食道炎的发生率及T淋巴细胞亚群的变化。 结果: 治疗组放射性食道炎的发生率为16.67%
对照组放射性食道炎的发生率为56.67%
两组比较有显著性差异(P<0.05)。治疗组在治疗后CD3+T细胞、CD4+T细胞、CD8+T细胞比例及CD4/CD8比值与治疗前比较差异有统计学意义(P <0.05)。对照组无变化。 结论: 应用自拟利咽方能降低放射性食道炎的发生率
提高患者的免疫力
对放射性食道炎的发生有一定的防治作用。
Objective: To observe the clinical effect of the self-control Liyan agents on the treatment for radiation esophagitis. Method: Sixty patients with lung cancer by radiotherapy were randomLy divided into two groups. The treatment group of thirty cases of beginning to end was given the self-control Liyan agents; thirty patients in the control group from beginning to end was given the common western medicine by mouth. Then evaluated any changes in the incidence of radiation esophagitis for the patients and T Lymphocyte subsets. Result: The incidence of radiation esophagitis in the treatment was 16.67%
and the control group’s incidence was 56.67%
there was significant differences between the two groups(P<0.05). After treatment the proportion of CD3+T cells
CD4+T cells
CD8+T cells and the CD4/CD8 ratio has statistical significance compared with those before treatment. And there was no change in the control group. Conclusion: Using the self-control Liyan agents could reduce the incidence of radiation esophagitis
improve the patients’ immunity
prevent certainly the emergence of radiation esophagitis.
0
浏览量
2
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621